+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Soft Mist Inhaler"

From
From
From
From
From
From
From
From
Metered Dose Inhaler Devices Market Report 2025 - Product Thumbnail Image

Metered Dose Inhaler Devices Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Aerosol Delivery Devices Market Report 2025 - Product Thumbnail Image

Aerosol Delivery Devices Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Inhalable Drugs Market Report 2025 - Product Thumbnail Image

Inhalable Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Soft Mist Inhalers - Global Strategic Business Report - Product Thumbnail Image

Soft Mist Inhalers - Global Strategic Business Report

  • Report
  • July 2025
  • 459 Pages
  • Global
From
Rescue Inhalers - Global Strategic Business Report - Product Thumbnail Image

Rescue Inhalers - Global Strategic Business Report

  • Report
  • July 2025
  • 582 Pages
  • Global
From
Inhalable Drugs - Global Strategic Business Report - Product Thumbnail Image

Inhalable Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 270 Pages
  • Global
From
Respiratory Inhalers - Global Strategic Business Report - Product Thumbnail Image

Respiratory Inhalers - Global Strategic Business Report

  • Report
  • July 2025
  • 620 Pages
  • Global
From
From
From
Loading Indicator

The Soft Mist Inhaler (SMI) is a type of inhaler used to deliver medication to the lungs. It is a breath-activated device that produces a fine mist of medication, which is then inhaled by the patient. SMIs are used to treat a variety of respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. They are also used to deliver medications for other conditions, such as allergies and COPD. SMIs are becoming increasingly popular due to their convenience and ease of use. They are also more cost-effective than other inhalers and nebulisers, making them a viable option for many patients. SMIs are also more discreet than other inhalers, making them a preferred choice for those who need to take their medication in public. The SMI market is highly competitive, with a number of companies offering a range of products. These include GlaxoSmithKline, Boehringer Ingelheim, Novartis, Merck, and AstraZeneca. Other companies in the market include 3M, Philips, and Teva Pharmaceuticals. Show Less Read more